Legal & General Group’s Humacyte HUMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.11K Sell
15,022
-595
-4% -$619 ﹤0.01% 3200
2025
Q4
$15K Buy
15,617
+3,608
+30% +$5.11K ﹤0.01% 3130
2025
Q3
$20.9K Hold
12,009
﹤0.01% 3016
2025
Q2
$25.1K Sell
12,009
-79,838
-87% -$153K ﹤0.01% 2915
2025
Q1
$157K Buy
91,847
+10,442
+13% +$39.2K ﹤0.01% 2640
2024
Q4
$411K Buy
81,405
+13,293
+20% +$65.8K ﹤0.01% 2530
2024
Q3
$371K Buy
68,112
+58,377
+600% +$385K ﹤0.01% 2559
2024
Q2
$46.7K Buy
9,735
+3,928
+68% +$20.4K ﹤0.01% 2807
2024
Q1
$18.1K Sell
5,807
-767
-12% -$2.58K ﹤0.01% 3007
2023
Q4
$18.7K Sell
6,574
-641
-9% -$1.65K ﹤0.01% 3059
2023
Q3
$21.1K Buy
7,215
+410
+6% +$1.36K ﹤0.01% 3003
2023
Q2
$19.5K Sell
6,805
-251
-4% -$905 ﹤0.01% 3124
2023
Q1
$21.8K Sell
7,056
-13,610
-66% -$38.7K ﹤0.01% 3043
2022
Q4
$43.6K Buy
20,666
+5,167
+33% +$15.7K ﹤0.01% 2970
2022
Q3
$51K Sell
15,499
-1,471
-9% -$5.64K ﹤0.01% 2969
2022
Q2
$55K Buy
16,970
+3,364
+25% +$18.7K ﹤0.01% 2991
2022
Q1
$96K Hold
13,606
﹤0.01% 2880
2021
Q4
$99K Buy
+13,606
New +$135K ﹤0.01% 2910

Other funds holding HUMA